Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Incannex Healthcare Limited American Depositary Shares (IXHL)

https://www.incannex.com.au

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/25/2022

Market Cap

28,404,960

Shares Outstanding

15,870,000

Weighted SO

15,870,103

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

DLTNF --.--%

RAMMF --.--%

CVGRF --.--%

BHHKF --.--%

SPBBF --.--%

EGRX --.--%

ANIP --.--%

PAHC --.--%

DCPH --.--%

Beta

2.2550

Last Div

0.0000

Range

0.8-12.68

Chg

-0.1800

Avg Vol

30324

Mkt Cap

28404960

Exch

NASDAQ

Country

AU

Phone

61 4 2570 3805

DCF Diff

1.0854

DCF

0.5756

Div Yield

0.0000

P/S

28.0161

EV Multiple

-0.6964

P/FV

1.8076

Div Yield %

0.0000

P/E

-1.2950

PEG

-0.2625

Payout

0.0000

Current Ratio

5.6980

Quick Ratio

8.0000

Cash Ratio

3.2490

DSO

2373.5031

DIO

-33743.8828

Op Cycle

-31370.3796

DPO

6423.2630

CCC

-37793.6426

Gross Margin

0.9297

Op Margin

-30.3773

Pretax Margin

-23.4453

Net Margin

-19.4643

Eff Tax Rate

0.3409

ROA

-1.1440

ROE

-0.6675

ROCE

-2.1409

NI/EBT

0.8302

EBT/EBIT

0.7718

EBIT/Rev

-30.3773

Debt Ratio

0.0237

D/E

0.0289

LT Debt/Cap

0.0172

Total Debt/Cap

0.0281

Int Coverage

0.0000

CF/Debt

-38.8143

Equity Multi

1.2201

Rec Turnover

0.1538

Pay Turnover

0.0568

Inv Turnover

-0.0108

FA Turnover

1.0890

Asset Turnover

0.0588

OCF/Share

-1.0001

FCF/Share

-1.0174

Cash/Share

0.5862

OCF/Sales

-15.6577

FCF/OCF

1.0173

CF Coverage

-38.8143

ST Coverage

-98.6028

CapEx Coverage

-57.8758

Div&CapEx Cov

-57.8758

P/BV

1.8076

P/B

1.8076

P/S

28.0161

P/E

-1.2950

P/FCF

-1.7589

P/OCF

-1.6098

P/CF

-1.6098

PEG

-0.2625

P/S

28.0161

EV Multiple

-0.6964

P/FV

1.8076

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 17, 07:30 Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea Benzinga Dec 29, 10:45 Global Mofy Metaverse Reports Follow-on Offering, Joins Lyft, Coinbase Global And Other Big Stocks Moving Lower On Friday GlobeNewswire Inc. Dec 06, 07:30 Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea The Motley Fool Dec 02, 06:41 These 3 Biotech Stocks More Than Doubled in November. Can They Fly Even Higher in 2024? GlobeNewswire Inc. Nov 29, 13:40 Incannex Healthcare Announces Completion of its Redomiciliation to the United States GlobeNewswire Inc. Nov 29, 13:40 Incannex Healthcare Announces Completion of its Redomiciliation to the United States GlobeNewswire Inc. Nov 16, 08:30 Federal Court of Australia Approves Incannex’s Re-Domiciliation and Lodgement of Court Orders With ASIC

Revenue Product Segmentation